Comment on 'Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis'
Moxon, Joseph V., Moran, Corey S., and Golledge, Jonathan (2017) Comment on 'Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis'. Clinical Science, 132 (1). pp. 37-38.
PDF (Published Version)
- Published Version
Restricted to Repository staff only |
DOI: 10.1042/CS20171522
View at Publisher Website: https://doi.org/10.1042/CS20171522
Abstract
Comment on article by Thompson and colleagues which reported the effects of inhibiting protein tyrosine phosphatase 1B (PTP1B) on the development of atherosclerosis within low-density lipoprotein receptor deficient (LDLR−/−) mice receiving either chow or high-fat diet.
Item ID: | 57946 |
---|---|
Item Type: | Article (Commentary) |
ISSN: | 1470-8736 |
Copyright Information: | © 2018 The Author(s). |
Date Deposited: | 12 Jan 2020 23:00 |
FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100% |
SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 100% |
Downloads: |
Total: 2 |
More Statistics |